Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...

The U.S. Food and Drug Administration on Wednesday approved Johnson & Johnson's drug to treat a type of muscle-weakening ...

The FDA approved nipocalimab (Imaavy) injection to treat adults and children ages 12 and older with generalized myasthenia ...

Health and Human Services employees were told in March to remove 'nicknames' from email systems and signatures to comply with ...

AI is a transformational force in healthcare, but without cybersecurity as its foundation, it becomes a high-stakes gamble.

Hoagie rolls and sourdough and whole grain multigrain loaves from Upper Crust Bakery LP have all been recalled ...

As food companies face pressure to eliminate artificial dyes, experts weigh in on the natural alternatives that could replace ...

People who have a sensitivity or allergy to milk may be at risk of an adverse reaction if they consume this product.

The US Food and Drug Administration has approved nipocalimab-aahu, a new FcRn- blocking monoclonal antibody, for the treatment of generalized myasthenia gravis.

The drug cytisinicline could help expand options for quitting smoking, and if approved by the FDA, would be the first new ...

IMAAVY TM (nipocalimab-aahu) is a first-in-class FcRn (neonatal Fc receptor) inhibitor, designed to reduce the levels of ...